Vyome Holdings (HIND) EPS (Basic) (QoQ) (2017 - 2026)
Vyome Holdings (HIND) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.10% |
| Mar 31, 2026 | 70.27% |
| Dec 31, 2025 | 79.45% |
| Sep 30, 2025 | 65.36% |
| Jun 30, 2025 | -111.86% |
| Mar 31, 2025 | 122.23% |
| Dec 31, 2024 | -9.94% |
| Sep 30, 2024 | 15.31% |
| Jun 30, 2024 | 32.35% |
| Mar 31, 2024 | 67.20% |
| Dec 31, 2023 | 72.16% |
| Sep 30, 2023 | 4.78% |
| Jun 30, 2023 | 31.11% |
| Mar 31, 2023 | 95.99% |
| Dec 31, 2022 | -44.40% |
| Sep 30, 2022 | -10.84% |
| Jun 30, 2022 | -11.17% |
| Mar 31, 2022 | -172.61% |
| Dec 31, 2021 | 88.87% |
| Sep 30, 2021 | -200.88% |